Severe dilated cardiomyopathy induced by adalimumab and ustekinumab

Saved in:
Bibliographic Details
Published inJournal of clinical rheumatology Vol. 21; no. 3; p. 171
Main Authors Membrillo de Novales, Francisco Javier, Ávila Jiménez, Alberto, Merino Meléndez, Leticia, Torres León, Juan, López Soberón, Edurne, Fe Marqués, Antonio, Pérez Mochales, Julio Francisco
Format Journal Article
LanguageEnglish
Published United States 01.04.2015
Subjects
Adalimumab - adverse effects
Adalimumab - therapeutic use
Antirheumatic Agents - adverse effects
Antirheumatic Agents - therapeutic use
Cardiomyopathy, Dilated - chemically induced
Cardiomyopathy, Dilated - diagnosis
Cardiomyopathy, Dilated - diagnostic imaging
Dermatologic Agents - adverse effects
Dermatologic Agents - therapeutic use
Echocardiography
Humans
Male
Middle Aged
Psoriasis - drug therapy
Severity of Illness Index
Ustekinumab - adverse effects
Ustekinumab - therapeutic use
Withholding Treatment
Online AccessGet more information

Cover

More Information
ISSN:1536-7355
DOI:10.1097/RHU.0000000000000237